Study: Antibiotic use in moderate COVID-19 linked to clinical deterioration

Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April)

Related Keywords

Germany ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Anette Friedrichs ,Escmid Global Congress ,Global Congress ,German National Pandemic Cohort Network ,University Hospital Schleswig Holstein ,Progression Scale ,Antibiotic ,Covid 19 ,Antimicrobial Resistance ,Bacteria ,Iagnostics ,Drugs ,Hospital ,Pandemic ,Pneumonia ,Public Health ,Research ,Espiratory ,Cars ,Ars Cov 2 ,